
Revas R 1.25mg Tablet
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Ramipril (1.25mg)
Overview Revas R 1.25mg Tablet
CardioGuard 1.25mg tablets are frequently prescribed for hypertension, congestive heart failure, and post-myocardial infarction management, significantly reducing the risk of future cardiac events, such as stroke. This medication can be administered independently or as part of a broader treatment regimen, with or without food. For optimal efficacy, consistent daily dosing is recommended; continued use is crucial even with symptom remission or controlled blood pressure, as untreated hypertension can worsen. CardioGuard 1.25mg is widely used and deemed safe for prolonged therapy. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your physician), complement its effects. Common, typically transient, side effects include dry cough, headache, and tiredness. Persistent or bothersome side effects warrant medical consultation. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver conditions; pregnant or lactating individuals require prior medical consultation. Regular monitoring of kidney function, blood pressure, and potassium levels may be undertaken during treatment.
Primary Ingredients of Revas R 1.25mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Revas R 1.25mg Tablet
Managing high blood pressure | Preventing cardiovascular events such as heart attack and stroke | Treating congestive heart failure
Major Benefits of Revas R 1.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Revas R 1.25mg Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Revas R 1.25mg Tablet:
- Dry cough
- Headache
- Fatigue
How to use Revas R 1.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Revas R 1.25mg Tablets can be administered with or without food, although consistent timing is recommended.
How Revas R 1.25mg Tablet works:
Revas R 1.25mg tablets contain an ACE inhibitor that eases cardiac workload and dilates blood vessels, thereby improving blood flow and boosting the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Revas R 1.25mg tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Revas R 1.25mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Use of Revas R 1.25mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Revas R 1.25mg Tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Revas R 1.25mg Tablets. Dosage modification may be necessary. Physician consultation is advised. Routine blood pressure checks are recommended to guide dosage alterations.
LiverCAUTION
Patients with liver impairment should exercise caution when using Revas R 1.25mg Tablets. Dosage modification may be necessary. Physician consultation is recommended. Report any signs or symptoms of jaundice to your doctor during treatment.
What if you forget to take Revas R 1.25mg Tablet :
Omit any missed Revas R 1.25mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Revas R 1.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Dipeptide Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | ACE inhibitors |
